Solid-phase synthesis of sialylglycopeptides through selective esterification of the sialic acid residues of an Asn-linked complex-type sialyloligosaccharide
Solid-phase synthesis of sialylglycopeptides through selective esterification of the sialic acid residues of an Asn-linked complex-type sialyloligosaccharide
复制标题
DOI:
10.1002/anie.200250572
复制
发表时间:
2003-01-01
影响因子:
16.6
通讯作者:
Kajihara, Y
中科院分区:
文献类型:
--
作者:
Yamamoto, N;Ohmori, Y;Kajihara, Y
Glycoproteins and glycopeptides contain O-or N-linked oligosaccharides on their peptide backbones and play a central role in several biological events.[1] Thus, it is essential to be able to synthesize glycoproteins and glycopeptides for use as probes to study their biological roles.[2–4] A chemoenzymatic method based on the solid-phase chemical synthesis of peptides and the enzymatic attachment of a sialyloligosaccharide to the peptide by the endoglycosidase enzyme Endo M has been reported for the synthesis of N-linked sialylglycopeptides.[3a, 4] However, as the enzyme used is not commercially available and as the enzymatic method often requires substrate specificity,[5] chemical synthesis is essential for the preparation of pure sialyloligosaccharides. To date there has been no solid-phase chemical synthesis of glycopeptides with the N-linked complex-type biantennary sialyloligosaccharide structure that is commonly found on glycoproteins reported, as there are two major problems concerning the solid-phase synthesis of these compounds.The first of these problems is the tendency of the sialyl linkage of glycopeptides to undergo acid-catalyzed hydrolysis in the presence of 95% trifluoroacetic acid (TFA) during the final cleavage step in solid-phase glycopeptide synthesis.[6] Both α-2, 6 and α-2, 3 sialyl linkages are very labile, but particularly the former. If α-2, 6 sialyloligosaccharides are to resist acid hydrolysis, an electron-withdrawing group such as an acetyl group should be used as a protecting group.[3g] Another way to avoid hydrolysis of the sialyl linkage is to use a sophisticated linker such as HYCRON, which can be cleaved under mild conditions.[7] The second problem is the quantity of complex-type sialyloligosaccharide required. If 10mg of a decapeptide (MW ca. 1000) is to be attached to a complex-type biantennary sialyloligosaccharide (MW ca. 2000) by solid-phase peptide synthesis, at least 20 mg of the oligosaccharide must be used.